Can you provide the average price target for MODERNA INC stock?
30 analysts have analysed MRNA and the average price target is 44.22 USD. This implies a price decrease of -13.22% is expected in the next year compared to the current price of 50.96.
MODERNA INC (MRNA) Forecast, Price Target & Analyst Ratings
NASDAQ:MRNA • US60770K1079
Current stock price
50.96 USD
-0.32 (-0.62%)
At close:
51.0435 USD
+0.08 (+0.16%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MODERNA INC (MRNA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$2.30
- Revenue Estimate
- 232.19M
Price Target Details & History
Consensus Price Target and Range
Mean target
$44.22
Upside
-13.22%
From current price of $50.96 to mean target of $44.22, Based on 30 analyst forecasts
Low
$12.12
Median
$40.80
High
$141.75
Price Target Revisions
1 Month
4.08%
3 Months
17.64%
Price Target Summary
30 Wall Street analysts provided a forecast for the next 12 months for MRNA. The average price target is 44.22 USD. This implies a price decrease of -13.22% is expected in the next year compared to the current price of 50.96.
The average price target has been revised upward by 17.64% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
56.00%
MRNA was analyzed by 30 analysts. The buy percentage consensus is at 56. So analysts seem to be rather neutral about MRNA.
In the previous month the buy percentage consensus was at a similar level.
MRNA was analyzed by 30 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-17 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-17 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-17 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-12 | Jefferies | Initiate | Hold |
| 2025-11-21 | Leerink Partners | Maintains | Underperform -> Underperform |
| 2025-11-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-21 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-11-10 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-11-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-23 | UBS | Maintains | Buy -> Buy |
| 2025-10-23 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-10-23 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-20 | Needham | Reiterate | Hold -> Hold |
| 2025-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-22 | Leerink Partners | Maintains | Underperform -> Underperform |
| 2025-08-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-22 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-05-22 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-05-02 | UBS | Maintains | Buy -> Buy |
| 2025-05-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-02 | Evercore ISI Group | Maintains | In-Line -> In-Line |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$2.30
- Revenue Estimate
- 232.19M
- Revenue Q2Q
- 114.99%
- EPS Q2Q
- 8.91%
- Number of Analysts
- 18
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-9.18%
EPS (1 Month)
-8.17%
EPS (3 Months)
-2.99%
Next Earnings Summary
MRNA is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -2.3 USD and the consensus revenue estimate is 232.19M USD.
The next earnings revenue estimate has been revised downward by 9.18% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.848B -64.45% | 3.236B -52.75% | 1.944B -39.93% | 2.114B 8.74% | 2.456B 16.18% | 2.947B 19.99% | 5.322B 80.59% | 6.957B 30.72% | 5.795B -16.70% | 6.657B 14.87% | 7.673B 15.26% | |
| EBITDA YoY % growth | -1.418B -114.52% | -3.261B -129.97% | -2.568B 21.25% | -2.531B 1.44% | -1.735B 31.46% | -923.018M 46.80% | 328.13M 135.55% | 1.958B 496.71% | 2.592B 32.38% | 3.204B 23.61% | 3.833B 19.63% | |
| EBIT YoY % growth | -2.039B -121.65% | -3.45B -69.20% | -2.783B 19.33% | -2.899B -4.17% | -2.112B 27.14% | -1.315B 37.73% | 205.57M 115.63% | 1.494B 626.76% | 1.508B 0.94% | 2.337B 54.97% | 2.829B 21.05% | |
| Operating Margin | -29.78% | -106.61% | -143.16% | -137.14% | -86.01% | -44.64% | 3.86% | 21.47% | 26.02% | 35.11% | 36.87% | |
| EPS YoY % growth | -12.41 -162.17% | -9.28 25.22% | -7.27 21.66% | -6.81 6.26% | -4.94 27.49% | -3.29 33.32% | 0.58 117.67% | 3.98 582.95% | 3.19 -19.84% | 4.53 42.08% | 5.93 30.86% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.30 8.91% | -2.14 -0.63% | -0.93 -82.60% | -1.43 32.36% | -2.05 10.53% | -2.16 -0.88% | -0.07 92.33% | -0.66 53.55% |
| Revenue Q2Q % growth | 232.19M 114.99% | 127.67M -10.09% | 987.64M -2.79% | 735.43M 8.47% | 201.4M -13.26% | 165.49M 29.62% | 1.299B 31.53% | 1.119B 52.16% |
| EBITDA Q2Q % growth | -1.064B -9.76% | -1.089B -40.92% | -574.153M -1,175.90% | -900.967M -80.92% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -879.986M 12.70% | -894.68M -2.96% | -422.173M -118.74% | -623.847M 12.50% | -849.405M 3.48% | -790.663M 11.63% | 101.19M 123.97% | 163.35M 126.18% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
15.65%
EPS Next 5 Year
20.56%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
15.21%
Revenue Next 5 Year
29.27%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
20.09%
EBIT Next 5 Year
20.77%
MODERNA INC / MRNA Forecast FAQ
What is the next earnings date for MRNA stock?
MODERNA INC (MRNA) will report earnings on 2026-04-30, before the market open.
Can you provide the consensus estimates for MODERNA INC next earnings?
The consensus EPS estimate for the next earnings of MODERNA INC (MRNA) is -2.3 USD and the consensus revenue estimate is 232.19M USD.
How do analysts rate MODERNA INC (MRNA)?
The consensus rating for MODERNA INC (MRNA) is 56 / 100 . This indicates that analysts generally have a neutral outlook on the stock.